Breaking News: AREV International Brands Ltd. (CSE: AREV) Corporate Update

AREV Brands International Ltd. (CSE: AREV), is pleased to announce that they have closed both the property purchase to acquire real estate in Sorrento, British Columbia and the Cana Gold asset purchase, both announced in January 2019. The Company would like to give the shareholder’s an update on our progress toward our vision for the Company.

AREV is an integrated natural health and therapeutics company with a focus on manufacturing innovative products that can utilize cannabis in their formulations. Our business is not to cultivate cannabis for use in the dried flower business. It is to focus on genetics and work with LP’s who are able to contract grow our genetics for us to repurchase for extraction into ingredients that will be used in our formulations.

In Canada, under the new Cannabis act, cannabis becomes a whole new legal industry. According industry research the edibles market is expected to out pace the dried flower market in 2019. Value-add processing of unique and innovative products will be the new driver in the market. Under this model LP’s will be growers and suppliers of extracts and edibles in addition to dried flower. AREV is poised to form form partnerships with LP’s for extraction and processing.

We have engaged Spire Secure Logistics Inc. to consult on obtaining a Hemp Cultivation License on the 28 acre Sorrento BC property and have initiated the construction of a 8,500 square foot processing facility, expected to be completed in the third quarter of 2019. The company has an extraction system and a soft gel cap machine to be installed at the new facility.

AREV has 8 products registered with Health Canada which have Natural Health Product numbers and a line of award winning topical creams, sticks and oils for pain management and skin care. We also recently acquired the High Times award winning line of Cannagold Vape Pens and concentrates.

Through our ownership in BC Bud Depot and with the assistance of our newest Director Mr. Leo Ford, we are able to start a breeding business in Columbia where we will be registering our genetics. Matt Harvey, the founder of the company recently visited Columbia and will be working with Leo to launch the business in Latin America. Matt has been developing and breeding cannabis for seeds and new strains successfully for over 20 years. As a result we own an extensive line of award winning stains and genetics. BC Bud Depot has one of the largest and revered seed banks in the world containing hundreds of genetics of which over 40 have won Cannabis Cups in International competitions. Our breeders are some of the best in the world.

–We have an inventory of approximately 850,000 seeds.

–Genetics vault with over 200 varieties

–Exclusive rights to the inside covers of High Times Magazine in perpetuity and it is pre paid.

–The web site has 2,000 new visits each week

–We have 50,000 names of customers in our database (15,000 in Canada)

Cannagold Concentrates

AREV recently acquired Cannagold line of Pens and Concentrates, which are well branded and ready to go in legal channels world wide.

BARE Topicals

An award winning line of topical creams, sticks and oils for pain management and skin care. People who use our most popular Heat, Recover and Magic swear by them. All natural and they work.

The Company held a meeting of the Board of Directors in Vancouver, British Columbia on February 20, 2019. The Board carefully reviewed the market, the Company’s assets and the future direction of the Company to best serve shareholders. As a result of these discussions, the Company has decided to focus their efforts on expanding the Company’s business into California and Columbia. The Company will continue to work through due diligence on JV opportunities with LP’s looking for extraction and genetics or product licensing.

In order to make room for another director in either California or Latin America and effective February 22, 2019 Stephane Maher, has resigned as a Director of the Company. The Company would like to thank Mr. Maher for all his work to date and wish you the best in all your future endeavors.

For further information, contact Mike Withrow, 778-379-8551.

On behalf of the Board,

Mike Withrow
CEO & Director

About AREV Brands International Ltd.: AREV Brands International Ltd. (“AREV”) produces and delivers functional compounds and ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.

Sponsored Content Release. Click for Full Disclosure

  1. Henry Pakala 8 months ago

    cannabis products are the future, I hope to see them replacing the common addictive opioids many of our healthcare practitioners prescribe today.

  2. Viktor Ferrera 8 months ago

    CBD topicals are amazing when it comes to relieving arthritis pain

Leave a Comment

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For arev brands international ltd. financial and corporate news dissemination, has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: